MD, MSc, PhD. Chief of Department of Internal Medicine, Centro de Investigación y Docencia en Ciencias de la Salud (CIDOCS), Culiacán, Mexico.
MD. Chief of the Hospital Epidemiological Unit, Hospital Civil de Culiacán, Culiacán, Mexico.
Sao Paulo Med J. 2022 Jul-Aug;140(4):566-573. doi: 10.1590/1516-3180.2021.0668.R1.121121.
Coronavirus disease 19 (COVID-19) is a multisystemic disease with high incidence of acute kidney injury (AKI).
To describe the clinical characteristics and factors associated with AKI among patients hospitalized with COVID-19.
Retrospective cohort conducted at Hospital Civil de Culiacan, Mexico.
We included 307 patients hospitalized due to COVID-19. AKI was defined and staged based on serum creatinine levels in accordance with the criteria of the Acute Kidney Injury Network (AKIN). Multivariate logistic regression analysis was used to determine factors associated with AKI.
The patients' age was 56 ± 15 years (64.5% male). The incidence of AKI was 33.6% (n = 103). Overall, 53.4% of patients had community-acquired AKI, and 46.6% had hospital-acquired AKI. Additionally, 15.5% of them presented AKIN stage 1; 34% had AKIN stage 2; and 50.5% had AKIN stage 3. Hemodialysis was required for 10.7% of the patients. The factors associated with AKI were chronic kidney disease (odds ratio, OR: 10.8; P = 0.04), use of norepinephrine (OR: 7.3; P = 0.002), diabetes mellitus (OR: 2.9; P = 0.03), C-reactive protein level (OR: 1.005; P = 0.01) and COVID-19 severity index based on chest tomography (OR: 1.09; statistical trend, P = 0.07). Hospital stay (11 ± 7 days; P < 0.001) and mortality (83.5 versus 31.4%; P < 0.05) were greater among patients with AKI.
AKI was a frequent and serious complication in our cohort of patients hospitalized with COVID-19, which was associated with high mortality and long hospital stay.
新型冠状病毒病(COVID-19)是一种多系统疾病,急性肾损伤(AKI)的发病率很高。
描述 COVID-19 住院患者中 AKI 的临床特征和相关因素。
在墨西哥库利亚坎市民医院进行的回顾性队列研究。
我们纳入了 307 名因 COVID-19 住院的患者。根据急性肾损伤网络(AKIN)的标准,根据血清肌酐水平定义和分期 AKI。使用多变量逻辑回归分析确定与 AKI 相关的因素。
患者年龄为 56 ± 15 岁(64.5%为男性)。AKI 的发生率为 33.6%(n = 103)。总体而言,53.4%的患者为社区获得性 AKI,46.6%为医院获得性 AKI。此外,15.5%的患者为 AKIN 1 期;34%为 AKIN 2 期;50.5%为 AKIN 3 期。10.7%的患者需要血液透析。与 AKI 相关的因素包括慢性肾脏病(优势比,OR:10.8;P = 0.04)、去甲肾上腺素的使用(OR:7.3;P = 0.002)、糖尿病(OR:2.9;P = 0.03)、C 反应蛋白水平(OR:1.005;P = 0.01)和基于胸部 CT 的 COVID-19 严重指数(OR:1.09;统计学趋势,P = 0.07)。AKI 患者的住院时间(11 ± 7 天;P < 0.001)和死亡率(83.5%比 31.4%;P < 0.05)更高。
AKI 是我们 COVID-19 住院患者队列中的一种常见且严重的并发症,与高死亡率和长住院时间相关。